CymitQuimica logo

CAS 2230821-40-4

:

INDEX NAME NOT YET ASSIGNED

Description:
As of my last update in October 2023, there is no specific information available regarding a chemical substance with the name "INDEX NAME NOT YET ASSIGNED" and CAS number 2230821-40-4. This could indicate that the substance is either newly synthesized, not widely studied, or still under evaluation for its properties and applications. Typically, chemical substances are characterized by their molecular structure, physical properties (such as melting point, boiling point, and solubility), chemical reactivity, and potential applications in various fields like pharmaceuticals, materials science, or industrial processes. For accurate and detailed information, it is advisable to consult scientific literature, databases, or regulatory agencies that may provide updates on newly assigned names and characteristics for such substances. If this compound is of particular interest, further research or inquiry into specialized chemical databases may yield more insights as they become available.
Formula:C57H61ClFN7O9S
Synonyms:
  • SJF 1521
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • SJF 1521
    Targetmol
    + Info

    SJF 1521

    CAS:
    <p>SJF 1521 is an EGFR degrader belonging to the PROTAC class that selectively degrades EGFR while preserving HER2.</p>
    Formula:C57H61ClFN7O9S
    Purity:99.20%
    Color and Shape:Solid
    Molecular weight:1074.65

    Ref: TM-T36244

  • EGFR PROTAC
    Apollo Scientific
    + Info

    EGFR PROTAC

    CAS:
    EGFR PROTAC
    Molecular weight:1,074.65g/mol

    Ref: 54-BIPC1043

    25mg
    824.00€
    50mg
    1,234.00€
    100mg
    1,866.00€
  • SJF-1521
    Fluorochem
    + Info

    SJF-1521

    CAS:
    Purity:98%
    Molecular weight:1073.39

    Ref: 10-F567704

    100mg
    1,061.00€
    250mg
    1,679.00€
  • SJF 1521
    Biosynth
    + Info

    SJF 1521

    CAS:
    SJF 1521 is an anticancer drug that is derived from indirubin, a traditional Chinese medicine. It belongs to the class of protein kinase inhibitors and has been shown to induce apoptosis in human tumor cells. SJF 1521 has potent inhibitory effects on various kinases involved in cancer cell growth and proliferation, making it a promising candidate for cancer treatment. This drug has been found to be effective against several types of cancer, including leukemia, lung cancer, and breast cancer. SJF 1521 is excreted primarily through urine and has been shown to have low toxicity levels. Its analogs are being studied for potential use in the treatment of other diseases such as Alzheimer's disease and inflammation.
    Formula:C57H61ClFN7O9S
    Purity:Min. 95%
    Molecular weight:1,074.7 g/mol

    Ref: 3D-FPD82140

    10mg
    757.00€
    25mg
    1,163.00€
    50mg
    1,861.00€